Matches in Wikidata for { <http://www.wikidata.org/entity/Q91801393> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q91801393 description "article scientifique publié en 2019" @default.
- Q91801393 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91801393 description "scientific article published on 18 February 2019" @default.
- Q91801393 description "wetenschappelijk artikel" @default.
- Q91801393 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91801393 name "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 name "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 type Item @default.
- Q91801393 label "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 label "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 prefLabel "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 prefLabel "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 P1433 Q91801393-FD305762-1AA7-49B6-81BA-7704D72CA06E @default.
- Q91801393 P1476 Q91801393-1A08F5D1-9CFE-401C-8AAB-D09E1DAB2250 @default.
- Q91801393 P2093 Q91801393-08116B14-9BF1-4E66-91DC-817F95E95A36 @default.
- Q91801393 P2093 Q91801393-25687136-8DA5-426E-BD6C-29BC66CFDD70 @default.
- Q91801393 P2093 Q91801393-41B2B4C8-BF10-49E5-A6DF-92D633F79F25 @default.
- Q91801393 P2093 Q91801393-4AE917C7-E9B8-48DE-9571-00830311C2D8 @default.
- Q91801393 P2093 Q91801393-523D1D8E-173F-426A-AA4E-A69E5EAFFD5A @default.
- Q91801393 P2093 Q91801393-5469B7F2-A829-4A4D-B52B-DAFEC3265577 @default.
- Q91801393 P2093 Q91801393-6EBF133B-26F6-49D6-91C3-7A6F7BADF84C @default.
- Q91801393 P2093 Q91801393-842700C4-A2DE-4B13-B786-AA99B27D1FCE @default.
- Q91801393 P2093 Q91801393-87A9096F-718D-42E1-8DFD-56FDC3DA486B @default.
- Q91801393 P2093 Q91801393-9302C554-2EF7-4036-A832-A608D7F3D3EE @default.
- Q91801393 P2093 Q91801393-A5A8212A-A84A-4A45-BF62-7F75AC5F56A1 @default.
- Q91801393 P2093 Q91801393-A8CDB192-91AA-4674-B61A-319AE02CFD1A @default.
- Q91801393 P2093 Q91801393-B4345AA2-91FC-4D42-9125-76ED06739261 @default.
- Q91801393 P2093 Q91801393-F24BC567-72EC-4A74-966E-63BF6D7886F1 @default.
- Q91801393 P304 Q91801393-AB74AC71-DDA3-4743-B964-37B9C5F8BF0A @default.
- Q91801393 P31 Q91801393-F395A733-8799-4C11-B635-9F89E8E61040 @default.
- Q91801393 P356 Q91801393-DB0234FA-D627-4403-9DA6-13E361DE4ABA @default.
- Q91801393 P478 Q91801393-D6B16565-6630-4635-A1FC-AE4BC9AC2DA4 @default.
- Q91801393 P50 Q91801393-8B11C058-D78D-4C36-A918-EB5FB38E182C @default.
- Q91801393 P50 Q91801393-F45DD6B6-5A90-4298-A8C7-031E4DAE206C @default.
- Q91801393 P577 Q91801393-59B30AC7-E456-4B3D-A6B8-1C4713518C81 @default.
- Q91801393 P698 Q91801393-FC0916A5-0E42-4012-9EE8-797786B91EBE @default.
- Q91801393 P356 J.CANLET.2019.02.028 @default.
- Q91801393 P698 30790678 @default.
- Q91801393 P1433 Q326372 @default.
- Q91801393 P1476 "Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase" @default.
- Q91801393 P2093 "Alessandro Fanciulli" @default.
- Q91801393 P2093 "Chiara Musuraca" @default.
- Q91801393 P2093 "Dana Banfi" @default.
- Q91801393 P2093 "Enrica Favaro" @default.
- Q91801393 P2093 "Ezio Ghigo" @default.
- Q91801393 P2093 "Giacomo Gamba" @default.
- Q91801393 P2093 "Ida Rapa" @default.
- Q91801393 P2093 "Laura Di Blasio" @default.
- Q91801393 P2093 "Luca Primo" @default.
- Q91801393 P2093 "Mauro Papotti" @default.
- Q91801393 P2093 "Paolo Gontero" @default.
- Q91801393 P2093 "Riccarda Granata" @default.
- Q91801393 P2093 "Stefania Munegato" @default.
- Q91801393 P2093 "Tania Villanova" @default.
- Q91801393 P304 "252-262" @default.
- Q91801393 P31 Q13442814 @default.
- Q91801393 P356 "10.1016/J.CANLET.2019.02.028" @default.
- Q91801393 P478 "449" @default.
- Q91801393 P50 Q85849462 @default.
- Q91801393 P50 Q87682207 @default.
- Q91801393 P577 "2019-02-18T00:00:00Z" @default.
- Q91801393 P698 "30790678" @default.